首页> 外文期刊>Molecular cancer research: MCR >Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells
【24h】

Downregulation of human farnesoid X receptor by miR-421 promotes proliferation and migration of hepatocellular carcinoma cells

机译:miR-421对人法呢素X受体的下调促进了肝癌细胞的增殖和迁移

获取原文
获取原文并翻译 | 示例
           

摘要

The farnesoid X receptor (FXR) is a member of the nuclear receptor superfamily that is highly expressed in liver, kidney, adrenal gland, and intestine. It plays an important role in regulating the progression of several cancers including hepatocellular carcinoma (HCC). So it is necessary to study the regulation of FXR. In this study, we found that the expression of miR-421 was inversely correlated with FXR protein level in HCC cell lines. Treatment with miR-421 mimic repressed FXR translation. The reporter assay revealed that miR-421 targeted 3′ untranslated region of human FXR mRNA. Furthermore, downregulation of FXR by miR-421 promoted the proliferation, migration, and invasion of HCC cells. These results suggest that miR-421 may serve as a novelmolecular target for manipulating FXR expression in hepatocyte and for the treatment of HCC.
机译:法尼醇X受体(FXR)是核受体超家族的成员,在肝,肾,肾上腺和肠中高表达。它在调节包括肝细胞癌(HCC)在内的几种癌症的进展中起着重要作用。因此有必要研究FXR的规定。在这项研究中,我们发现miR-421的表达与HCC细胞系中的FXR蛋白水平呈负相关。用miR-421模拟物处理可抑制FXR翻译。报道分子测定揭示了miR-421靶向人FXR mRNA的3'非翻译区。此外,miR-421对FXR的下调促进了HCC细胞的增殖,迁移和侵袭。这些结果表明,miR-421可以作为操纵肝细胞中FXR表达和治疗HCC的新分子靶标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号